CLEC7A and neoplasm: Dectin-1-activated DCs can also induce the maturation and proliferation of CD8+ T cells in vitro: the Dectin-1 agonist curdlan was found to act as an adjuvant for cytotoxic T lymphocyte cross-priming in vivo, which elicited potent responses capable of protecting mice from experimental tumor challenges (35).